Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,663 | -3,248 | -5,013 | 340 | -9,705 |
| Depreciation Amortization | 584 | 375 | 220 | 9 | 37 |
| Income taxes - deferred | -9,500 | -4,848 | -2,416 | -990 | N/A |
| Accounts payable and accrued liabilities | -3,196 | -2,907 | -3,237 | 758 | 314 |
| Other Working Capital | -3,618 | -3,178 | -10,049 | -3,272 | 399 |
| Other Operating Activity | -1,604 | -2,211 | 4,085 | -155 | -135 |
| Operating Cash Flow | $-22,997 | $-16,017 | $-16,410 | $-3,310 | $-9,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 32,470 | -18 | -14 | N/A | -2 |
| Net Acquisitions | 84,179 | 84,179 | 84,179 | 84,179 | N/A |
| Purchase Of Investment | N/A | 32,500 | N/A | N/A | N/A |
| Investing Cash Flow | $116,649 | $116,661 | $84,165 | $84,179 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -27 | -27 | -16 | N/A | N/A |
| Common Stock Issued | 140 | 6 | N/A | N/A | 22 |
| Common Stock Repurchased | N/A | N/A | 6 | N/A | N/A |
| Other Financing Activity | -38 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $75 | $-21 | $-10 | $N/A | $22 |
| Beginning Cash Position | 4,952 | 4,952 | 4,952 | 4,952 | 14,022 |
| End Cash Position | 98,679 | 105,575 | 72,697 | 85,821 | 4,952 |
| Net Cash Flow | $93,727 | $100,623 | $67,745 | $80,869 | $-9,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,997 | -16,017 | -16,410 | -3,310 | -9,090 |
| Capital Expenditure | -30 | -18 | -14 | N/A | -2 |
| Free Cash Flow | -23,027 | -16,035 | -16,424 | -3,310 | -9,092 |